RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 96.45
+1.08 (1.13%)
At close: Dec 5, 2025
RemeGen Revenue
RemeGen had revenue of 621.88M CNY in the quarter ending September 30, 2025, with 33.13% growth. This brings the company's revenue in the last twelve months to 2.23B, up 46.34% year-over-year. In the year 2024, RemeGen had annual revenue of 1.72B with 58.54% growth.
Revenue (ttm)
2.23B
Revenue Growth
+46.34%
P/S Ratio
22.61
Revenue / Employee
742.85K
Employees
2,999
Market Cap
50.36B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 30.98B |
| WuXi AppTec | 43.88B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Sichuan Biokin Pharmaceutical | 2.23B |
| Shanghai United Imaging Healthcare | 12.20B |
| Aier Eye Hospital Group | 22.17B |
| Zhangzhou Pientzehuang Pharmaceutical., | 9.78B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |